Minimed Group Financials - Benzinga

Minimed Group Inc

MMEDNASDAQ

Trade with Public

Trade with Public

$20.44

-0.1-0.49%

À la clôture: Sep 23, 5:00 PM EST

$20.40

-0.14-0.68%

Pré-ouverture: 6:04 AM EST

Aperçu Actualités Prévisions de résultats Événements Objectifs de coursDonnées financièresSentiment Comparer Options Rapport sur les stocks

Minimed Group Financials

Minimed Group (MMED) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

These Analysts Boost Their Forecasts On MiniMed Group Following Q1 Sales Results

MiniMed Group beat Q1 sales estimates with 16.6% growth to $843M; shares rose 7.1% as analysts raised price targets to $26-$28.

Avi Kapoor

PRO
Minimed Group Q1 Sales $843.000M Beat $827.065M Estimate

Minimed Group (NASDAQ:MMED) reported quarterly sales of $843.000 million which beat the analyst consensus estimate of $827.065 million by 1.93 percent. This is a 16.60 percent increase over sales of $723.000 million

Benzinga Newsdesk

Top Wall Street Forecasters Revamp MiniMed Group Expectations Ahead Of Q1 Earnings

MiniMed Group, Inc. (MMED) will report Q1 earnings on Sept. 1. Analysts expect 9 cents/share, down from 35 cents/share last year. Stock closed at $19.51.

Avi Kapoor

Earnings Scheduled For June 3, 2026

Benzinga Insights

PRO
Minimed Group Q4 EPS $(0.68) Misses $0.11 Estimate, Sales $837.000M Beat $789.096M Estimate

Minimed Group (NASDAQ:MMED) reported quarterly losses of $(0.68) per share which missed the analyst consensus estimate of $0.11 by 718.18 percent. This is unchanged from the same period last year. The company reported

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved